Sangang Wu
Overview
Explore the profile of Sangang Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao L, Pang Y, Zheng H, Han C, Gu J, Sun L, et al.
Eur J Nucl Med Mol Imaging
. 2021 Apr;
48(11):3606-3617.
PMID: 33792760
Purpose: This study aimed to explore the clinical utility of [Ga]Ga-labeled fibroblast activation protein inhibitor ([Ga]Ga-FAPI) positron emission tomography/computed tomography (PET/CT) relative to [F]-fluorodeoxyglucose ([F]FDG) PET/CT and magnetic resonance imaging...
2.
Zou K, Chen W, Dai J, Mo P, Yu C, Xu J, et al.
Inflammation
. 2021 Jan;
44(3):1145-1159.
PMID: 33398542
Inflammation theory has suggested that the pathogenesis of postoperative ileus (POI) involves the steroid receptor coactivator-3 (SRC-3). Therefore, we investigated the role of SRC-3 in the muscles of the small...
3.
Tang L, Wang X, Wu J, Li S, Zhang Z, Wu S, et al.
Invest Ophthalmol Vis Sci
. 2019 Jan;
59(13):5494-5508.
PMID: 30658033
Purpose: To determine if sleep deprivation induces dry eye through altering peroxisome proliferator-activated receptor alpha (PPARα) expression in mice. Methods: The "stick over water" sleep deprivation-induced dry eye (SDE) model...
4.
Liao X, Zhao L, Wu S, Zheng H, Chen H, Zhang H, et al.
Oncotarget
. 2018 Jan;
8(68):113287-113293.
PMID: 29348907
The US FDA granted accelerated approval to pembrolizumab for microsatellite instability-high and mismatch repair deficient cancers. The response of programmed death-1 blockade in mismatch repair proficiency (pMMR) colorectal cancer is...
5.
Yang L, Guo H, Li Y, Meng X, Yan L, Zhang D, et al.
Sci Rep
. 2016 Oct;
6:34611.
PMID: 27721381
The present study aimed to examine the anti-inflammatory actions of oleoylethanolamide (OEA) in lipopolysaccharide (LPS)-induced THP-1 cells. The cells were stimulated with LPS (1 μg/ml) in the presence or absence...
6.
Lai Y, Chen Y, Wu S, Shi L, Fu L, Ha H, et al.
Medicine (Baltimore)
. 2016 Apr;
95(14):e3295.
PMID: 27057896
Conventional volumetric modulated arc therapy (C-VMAT) for breast cancer after radical mastectomy had its limitation that resulted in larger volumes of normal tissue receiving low doses. We explored whether there...
7.
Wu S, Lai Y, He Z, Zhou Y, Chen S, Dai M, et al.
PLoS One
. 2015 Mar;
10(3):e0120811.
PMID: 25781183
Objectives: To compare the target volume coverage and doses to organs at risks (OARs) using three techniques that simultaneous integrated boost (SIB) in whole-breast irradiation (WBI) after breast-conserving surgery, including...
8.
Chen J, Wu S, Zheng X, Pan J, Zhu K, Chen Y, et al.
BMC Surg
. 2014 Dec;
14:110.
PMID: 25527100
Background: Lymph node metastasis (LNM) is most common in esophageal squamous cell carcinoma (SCC). The bi-directional spread is a key feature of LNM in patients with thoracic esophageal SCC (TE-SCC)....
9.
Wu S, Li Q, Zhou J, Sun J, Li F, Lin Q, et al.
Ther Clin Risk Manag
. 2014 Oct;
10:867-74.
PMID: 25328402
Introduction: This retrospective study investigated the clinical value of post-mastectomy radiotherapy (PMRT) in female Chinese breast cancer patients aged 35 years or younger with positive axillary lymph nodes after mastectomy....
10.
He Z, Wu S, Zhou J, Li F, Sun J, Lin Q, et al.
J Breast Cancer
. 2014 Oct;
17(3):256-64.
PMID: 25320624
Purpose: Several accelerated partial breast irradiation (APBI) techniques are being investigated in patients with early-stage breast cancer. The present study evaluated the feasibility, early toxicity, initial efficacy, and cosmetic outcomes...